Key View
- Malaysia’s medical device market will register a high single-digit CAGR over the 2024-2029 period.
- Malaysia’s medical device exports will continue to evolve, with significant changes in the composition of exported product categories evident over the past decade.
- While exports grew rapidly in 2024, Malaysia’s medical device exports are unlikely to maintain this pace in 2025 or 2026, as higher US tariffs and the market’s heavy reliance on US demand expose the sector to significant downside risks.
- The signing of a medical device regulatory agreement with Mainland China marks a significant step in Malaysia’s efforts to diversify its export markets.
Malaysia’s medical device market will register a high single-digit compound annual growth rate (CAGR) over the 2024-2029 period. We forecast that Malaysia’s medical device market will reach a value of MYR18.1bn (USD3.9bn) by 2029, recording a 2024-2029 CAGR of 7.6% in local currency and 7.1% in US dollar terms. This growth will be driven by rising demand for healthcare services driven by demographic factors including the ageing population, an increase in chronic diseases, rising government expenditure and an expanding private sector. The modernisation of healthcare facilities will drive demand for products while increasing domestic production capacity will also support growth. A key downside risk to our forecasts is Malaysia’s anticipated slowdown in economic growth, which our Country Risk team expects to average 4% over the next 10 years. Key reasons for this include reduced demand for Malaysian exports amid evolving global trade dynamics and the decline in Malaysia’s working age population, which is expected to reduce labour income revenues and hinder the government’s capacity to spend on social services.
Malaysia’s medical device industry has shown impressive diversification, contributing significantly to the nation’s export economy. This sector is notable for its wide range of products, including surgical instruments, diagnostic equipment, and orthopedic devices. The country’s robust manufacturing capabilities and adherence to global standards have facilitated its growth, making Malaysia a reputable player in this field.
A key factor in this diversification is the collaboration between the government and private sector. Through initiatives like the Medical Device Authority (MDA) and various innovation grants, companies are encouraged to advance and diversify their offerings. This has not only enabled Malaysian firms to meet international demands but also to penetrate various global markets with specialized products, enhancing their competitive edge and reputation worldwide.
Looking ahead, Malaysia is poised to expand its medical device exports into mainland China. With China’s growing healthcare demands and Malaysia’s strategic focus on quality and innovation, this expansion represents a significant opportunity. Strengthening trade relations and adapting to local regulatory requirements will be crucial in capitalizing on this burgeoning market.
Read More
